Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 849 results for "novartis"

Novartis AG (NVS) is Bourgeon Capital Management LLC's 9th Largest Position

Novartis: Peak Patent Exposure Offers Opportunity

Novartis AG (NYSE: NVS ) is a large pharmaceutical firm based in Switzerland. Its shares trade on the NYSE as an American Depository Receipt, or ADR. The company was created by the merger of Sandoz AG and Ciba-Geigy AG in December 1996. It is ... Seeking Alpha, 6 hours ago

690 images for novartis

WKRB News, 4 hours ago
American Banking News, 8 hours ago
American Banking News, 12 hours ago, 2 days ago, 2 days ago
PharmaVOICE, 2 days ago, 1 day ago
American Banking News, 2 days ago
pharmaphorum, 1 day ago, 2 days ago

Novartis India to hold board meeting

On 11 November 2016
 Business Standard14 hours ago Novartis India's board meeting on November 11, 2016  Money Control19 hours ago

Pfizer Continues to Work on Ibrance Label Expansion in 2016

Pfizer (PFE) expects Ibrance to pose strong competition to upcoming CDK 4/6 inhibitor therapies from Novartis (NVS) and Eli
 Yahoo! Finance14 hours ago Toviaz Expected to Report Stable Revenues in 2016  Yahoo! Finance2 days ago
Motley Fool

Novartis' Is Challenging Biogen on Biogen's Own Turf

Biogen Inc. ( NASDAQ:BIIB ) may be the Goliath in the $17 billion (and growing) market for multiple sclerosis (MS) treatment, but it's Novartis ' ( NYSE:NVS ) Gilenya, not Biogen's Tecfidera, that's growing more quickly this year. Image ...
 Motley Fool1 day ago Novartis AG Is Challenging Biogen On s Own Turf  BioSpace8 hours ago Biogen Flat For 3 Years While EPS Rise 150%; Is It A Buy Yet?  Seeking Alpha3 hours ago

Global Anti-Hypertensive Drugs Market Report 2014-2021 - Analysis, Technologies & Forecasts - Vendors: Novartis, Pfizer, Sanofi - Research and Markets

DUBLIN--(BUSINESS WIRE)-- Research and Markets has announced the addition of the "Anti-Hypertensive Drugs Market: By Drugs Type (Diuretics, Calcium channel blockers, Angiotensin-converting enzyme (ACE) inhibitors, Angiotensin II receptor ...
 Benzinga.com1 day ago Global Active Pharma Ingredient Sales Market Report 2016 Teva DSM Novartis Johnson?&?Johnson Dr. Reddy's Pfizer Bayer BASF Cambrex Sun Pharmaceutical  MyNewsDesk2 days ago Global Auto-Injectors Market - Analysis, Technologies & Forecasts to 2022 - Key Vendors are Pfizer, Antares Pharma & Novartis - Research and Markets  Business Wire8 hours ago Neprilysin - Pipeline Review, H2 2016 - Key Vendors are Bioprojet, Novartis & Pharmaleads - Research and Markets  TMC Net1 day ago
Business Line

China gets it right, not India, says Novartis chief

In June this year, Swiss drug-major Novartis opened its seven-building research base in Shanghai, China. The facility involves a $1 billion commitment from the multinational, making it Novartis third major research centre after Basel (Switzerland) and ...
 Business Line1 day ago

Novartis Looks at Up to $5 Billion Deals in Cancer, Generics

Novartis AG, Europe's second-biggest drugmaker by sales, said it's looking for acquisitions that cost between $2 billion and $5 billion to bolster its position in areas including cancer and the development of copycat medicines. If there were ...
 Bloomberg2 days ago Novartis AG Has Up to $5 Billion Burning in Its Pocket for M&As  BioSpace1 day ago Novartis Profit Falls as Generics Hurt Sales of Gleevec Drug  Yahoo! Finance2 days ago Novartis Profit Declines as Competition Hits Cancer Drug Sales  La Repubblica2 days ago

Europe stocks fall as healthcare heavyweights slide on earnings

A two-day lull for European equities ended as Novartis AG led drugmakers down after reporting earnings. The Swiss maker of cancer treatments slid 2.8%, the biggest drag on the Stoxx Europe 600 Index, after its profit fell for a seventh straight ...
 Moneyweb2 days ago European Stocks Fall as Novartis Drags Health-Care Shares Lower  La Repubblica2 days ago European markets open higher; earnings to dominate  Money Control2 days ago

Novartis AG 2016 Q3 - Results - Earnings Call Slides

Oct.25.16 | About: Novartis AG (NVS) The following slide deck was published by Novartis AG in conjunction with their 2016 Q3 earnings call. Click
 Seeking Alpha2 days ago Novartis AG (NVS) Q3 2016 Results - Earnings Call Transcript  Seeking Alpha2 days ago Life science earnings: LabCorp, Merck, Novartis  Local Tech Wire1 day ago GlaxoSmithKline's (GSK) CEO Andrew Witty on Q3 2016 Results - Earnings Call Transcript  Seeking Alpha1 day ago
Business Insider

Novartis CEO thinks the drug pricing debate will get 'more difficult' in the next 3-5 years (NVS)

ZURICH (Reuters) - Novartis expects a more difficult pricing environment for drugs in the United States in the years ahead, its chief executive told a results conference call on Tuesday. "We expect pricing to become more difficult in the U.S.
 Business Insider2 days ago Novartis CEO sees tougher U.S. drug pricing over next 3-5 years  Yahoo! Finance2 days ago Novartis AG CEO Thinks The Drug Pricing Debate Will Get "More Difficult" In The Next 3-5 Years  BioSpace1 day ago Novartis CEO sees tougher US drug pricing over next three-five years  Channel NewsAsia2 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - novartis
Get updated on latest news & your favorite topics right in your inbox!
More     Less